Overview
G6PD deficiency is an X-linked inherited blood disorder in which the body doesn’t have enough of the enzyme G6PD. This means that if a boy (XY) receives an X chromosome that is deficient, he will have a significant G6PD deficiency. A girl (XX) can receive either one deficient X chromosome, or two. This means that girls can have more varied levels of G6PD deficiency, from non-symptomatic to highly deficient. Even some girls who are carriers (one good X and one bad X) have been found to be symptomatic. Some females are more highly deficient than expected, because they have one deficient X chromosome and a second mutated and/or damaged X chromosome.
- This is the most common inherited enzyme defect in the world.
- With the right precautions, a child with G6PD deficiency can lead a healthy and active life.
- G6PD deficiency is common in Guangdong, Taiwan, Guangxi and other parts of South China. It is found in the Han, Zhuang, Li and Miao ethnic groups, as well as others.
- In China many of those affected with G6PD deficiency have less than 10% enzyme activity, resulting in a high degree of sensitivity to oxidizing substances.
- Some of the G6PD variants result in chronic hemolytic anemia (CNSHA).
- G6PD deficiency is thought to be a defense against Malaria and occurs in the same regions as the Thalassemias. A person can have both Thalassemia, major or trait and G6PD deficiency.
- Tests for G6pd deficiency in boys are easily administered and reliable.
- Tests for G6pd deficiency in girls are difficult, expensive and often require genetic analysis. However in China new more reliable, less expensive tests are being developed to detect G6PD deficiency in girls.
- G6PD deficiency in women has been found to become more acute as they age.
- Those who are G6PD deficient are likely to have an increased risk of diabetes, hypertension, sepsis and its complications and cataracts.
Things to avoid
Each person, and each G6PD variant (approximately 400) can react differently to identified trigger substances. There are however, accepted lists of substances that may need to be avoided.
These include:
- NSAIDS (Asprin, Ibuprophen)
- Tylenol
- Quinolones
- Drugs metabolized through the liver or known to cause blood or liver related problems or hemolysis
- Sulfa drugs
- Petrochemically derived substances (This is a long list and gets longer every year. Many artificial foods, dyes and vitamins are included in this list.)
- Moth Balls and anything containing naphthalene.
- Methylene and Toluidine blue
- Legumes and their derivatives (for example: soy, peanut, beans, peas, licorice, food thickeners and gums, MSG)
- Other substances including blueberries, blue food coloring, tonic water/quinine, red wine, sulfites, mothballs, and petroleum derived substances.
- Illness / fever can also trigger G6PD symptoms.
Symptoms
Symptoms can be found in both those who have been diagnosed (boys and some girls) and those who have not yet been diagnosed (esp. in girls from South China / SE Asia). Symptoms generally occur within three days of exposure to triggering substance. Once the triggering substance is removed or the illness resolved, the symptoms generally improve over a period of weeks. Mild symptoms can be treated at home, more severe symptoms may require hospitalization.
- paleness (in darker-skinned children paleness is sometimes best seen in the mouth, especially on the lips or tongue)
- extreme tiredness
- rapid heartbeat
- rapid breathing or shortness of breath
- an enlarged spleen
- dark, tea-colored urine
- abdominal / back pain
- bruising
- fever
- weakness
- dizziness
- confusion
Classes of G6PD Enzyme Variants:
| Class | Level of deficiency | Enzyme activity | Prevalence |
|---|---|---|---|
I
|
Severe
|
Chronic nonspherocytic hemolytic anemia in the presence of normal erythrocyte function
|
Uncommon; occurs across populations
|
II
|
Severe
|
Less than 10 percent of normal
|
Varies; more common in Asian and Mediterranean populations
|
III
|
Moderate
|
10 to 60 percent of normal
|
10 percent of black males in the United States
|
IV
|
Mild to none
|
60 to 150 percent of normal
|
Rare
|
V
|
None
|
Greater than 150 percent of normal
|
Rare
|
Adapted from AAFP.org
Resources
• www.g6pddeficiency.org
• www.rialto.com
• www.g6pd.org
• www.ghr.nlm.nih.gov
• www.nlm.nih.gov/medlineplus/ency/article/000528.htm
• memo.cgu.edu.tw/cgmj/2809/280902.pdf
• www.hkcpath.org/docs/Topical%20Update/Topical%20Update%20V2I1.pdf
• www.aafp.org/afp/2005/1001/p1277.html
• www.bioinf.org.uk/g6pd/
• Hirono A, Fujii H, Miwa S. Identification of two novel deletion mutations in glucose-6-phosphate dehydrogenase gene causing hemolytic anemia. Blood 1995;85:1118-21.
• Mason PJ, Sonati MF, MacDonald D, et al. New glucose-6-phosphate dehydrogenase mutations associated with chronic anemia. Blood 1995;85:1377-80.





